
Liquidity, historical trends, and peer comparisons.
According to Valneva SE’s latest financial reports and current stock price. The company's current Current Ratio is 2.16. This represents a change of 1.95% compared to the average of 2.12 of the last 4 quarters.
The mean historical Current Ratio of Valneva SE over the last ten years is 2.21. The current 2.16 Current Ratio has changed -2.59% with respect to the historical average. Over the past ten years (40 quarters), VALN's Current Ratio was at its highest in in the March 2019 quarter at 4.25. The Current Ratio was at its lowest in in the September 2021 quarter at 0.
Average
2.21
Median
2.28
Minimum
1.53
Maximum
3.13
Discovering the peaks and valleys of Valneva SE Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 57.74%
Maximum Annual Current Ratio = 3.13
Minimum Annual Increase = -43.93%
Minimum Annual Current Ratio = 1.53
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 2.38 | -8.63% |
| 2024 | 2.61 | 57.74% |
| 2023 | 1.65 | 8.07% |
| 2022 | 1.53 | -3.58% |
| 2021 | 1.59 | -9.47% |
| 2020 | 1.75 | -43.93% |
| 2019 | 3.13 | 6.62% |
| 2018 | 2.93 | 32.43% |
| 2017 | 2.22 | -5.55% |
| 2016 | 2.35 | -6.58% |
The current Current Ratio of Valneva SE (VALN) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
2.22
5-year avg
1.95
10-year avg
2.21
Valneva SE’s Current Ratio is less than Novavax, Inc. (2.33), less than Vir Biotechnology, Inc. (6.04), less than Arcturus Therapeutics Holdings Inc. (5.88), greater than GeoVax Labs, Inc. (1.54), less than Vaxcyte, Inc. (5.72), less than Moderna, Inc. (2.29), greater than Inovio Pharmaceuticals, Inc. (1.00), less than Evaxion Biotech A/S (5.06), greater than CEL-SCI Corporation (1.48), less than ImmunityBio, Inc. (5.72),
| Company | Current Ratio | Market cap |
|---|---|---|
| 2.33 | $1.59B | |
| 6.04 | $1.89B | |
| 5.88 | $278.97M | |
| 1.54 | $1.66M | |
| 5.72 | $9.55B | |
| 2.29 | $89.22B | |
| 1.00 | $142.33M | |
| 5.06 | $18.76M | |
| 1.48 | $23.75M | |
| 5.72 | $8.48B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Valneva SE using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Valneva SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Valneva SE's Current Ratio?
How is the Current Ratio calculated for Valneva SE (VALN)?
What is the highest Current Ratio for Valneva SE (VALN)?
What is the 3-year average Current Ratio for Valneva SE (VALN)?
What is the 5-year average Current Ratio for Valneva SE (VALN)?
How does the current Current Ratio for Valneva SE (VALN) compare to its historical average?